Trial intelligence / Profile preview

Hainosankyuto plus amoxicillin for acute periodontal inflammatory lesions

jRCTs071260057Not yet recruiting

Start
Jul 2026
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial in gingival disease, periodontal abscess and periodontitis comparing Intervention: amoxicillin + Hainosankyuto with Control: amoxicillin alone (2 arms). Primary endpoints: Local inflammatory findings assessed by dentist at day 30, OHIP-14 total and subdomain scores at day 30 and 4 more. Planned start Jul 2026; status: not yet recruiting.

02

Drugs

hainosankyutoamoxicillin
03

Conditions

gingival diseaseperiodontal abscessperiodontitis

Beyond the preview

Go deeper on jRCTs071260057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs071260057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call